The primary end point was a plasma HIV type 1 RNA level of at least 50 copies per milliliter at week 48, assessed on the basis of the Food and Drug Administration snapshot algorithm.
According to researchers, AMR could kill up to 10 million people by the year 2050. A 2019 Lancet report estimated global deaths associated with bacterial AMR of close to 5 million people.